Omer Raheem
Urology · Chicago, ILNPI 1336436252
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.5%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Antares Pharma, Inc. at 52.6% of the total. Reporting peaked in 2023 at $77,246 and has fallen 96.1% since, to $3,016 in 2025. Among urology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $654.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Antares Pharma, Inc.$78K
- Coloplast$54K
- Acerus Pharmaceuticals Corporation$6K
- Mylan Inc.$3K
- Boston Scientific$3K
- Procept Biorobotics Corporation$1K
- plus $2K from 14 others
Across 11 payments — averaging $5128.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$31K
- AbbVie$26K
What the payments were for
- Consulting fees$8,9696%
- Speaking & faculty fees$68,82447%
- Grants$46,60932%
- Travel & lodging$13,6669%
- Food & beverage$9,7027%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Antares Pharma, Inc. | 66 | $77,800 |
| Coloplast | 62 | $54,439 |
| Acerus Pharmaceuticals Corporation | 11 | $6,476 |
| Mylan Inc. | 5 | $3,354 |
| Boston Scientific | 42 | $2,957 |
| Procept Biorobotics Corporation | 9 | $1,210 |
| Neotract Inc. | 5 | $428 |
| Halozyme Inc | 5 | $291 |
| Olympus America Inc. | 4 | $238 |
| Astellas Pharma US Inc | 4 | $179 |
| Innovation Technologies Inc | 2 | $141 |
| Teleflex LLC | 1 | $139 |
| Aytu Biopharma, Inc. | 1 | $61 |
| Clarus Therapeutics Inc. | 3 | $27 |
| Tempus AI, Inc | 1 | $26 |
| Urogen Pharma, Inc. | 1 | $23 |
| Travere Therapeutics, Inc. | 1 | $22 |
| Cook Medical LLC | 1 | $22 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Tolmar, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TLANDO$69,729
- TITAN$52,606
- XYOSTED$43,130
- Natesto$6,196
- VIAGRA$3,297
- AquaBeam Robotic System$942
- AMS$555
- AMS 700 CXR RTE KIT$467
- UroLift$381
- GENERAL ERECTILE DYSFUNCTION$364
- NOCDURNA$346
- VIRTUE$174
- GENERAL - THERAPIES$164
- UroLift System$139
- CYTUITY$125
- ALTIS$119
- AMBICOR$108
- Irrisept$101
How this compares
$147,870 in reported general payments places this provider in the 95th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 45 | $1,005 |
| Finasteride | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Other urology in Chicago
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Amy KrambeckChicago$356K
- Kevin ZornChicago$274K
- Joshua MeeksChicago$248K
- Edward SchaefferChicago$209K
- Paul YonoverChicago$179K
- Piyush AgarwalChicago$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.